These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32971119)

  • 1. An in vitro refolding method to produce oligomers of anti-CHIKV, E2-IgM Fc fusion subunit vaccine candidates expressed in E. coli.
    Kumar S; Singh VK; Vasam M; Patil PS; Dhaked RK; Ansari AS; Lohiya NK; Parashar D; Tapryal S
    J Immunol Methods; 2020 Dec; 487():112869. PubMed ID: 32971119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virus-neutralizing antibodies in mice.
    Khan M; Dhanwani R; Rao PV; Parida M
    Virus Res; 2012 Aug; 167(2):236-46. PubMed ID: 22610133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
    Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus.
    Kumar M; Sudeep AB; Arankalle VA
    Vaccine; 2012 Sep; 30(43):6142-9. PubMed ID: 22884660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Highly Expressing, Soluble, and Stable Plant-Made IgG Fusion Vaccine Strategy Enhances Antigen Immunogenicity in Mice Without Adjuvant.
    Diamos AG; Pardhe MD; Sun H; Hunter JGL; Kilbourne J; Chen Q; Mason HS
    Front Immunol; 2020; 11():576012. PubMed ID: 33343565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits.
    Metz SW; Martina BE; van den Doel P; Geertsema C; Osterhaus AD; Vlak JM; Pijlman GP
    Vaccine; 2013 Dec; 31(51):6092-6. PubMed ID: 24099875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immune response against newly emerging goose tembusu virus infection induced by immunization with a recombinant envelope protein.
    Zhao D; Huang X; Han K; Liu Y; Yang J; Liu Q; An F; Li Y
    Lett Appl Microbiol; 2015 Oct; 61(4):318-24. PubMed ID: 26108865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate.
    Saraswat S; Athmaram TN; Parida M; Agarwal A; Saha A; Dash PK
    PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004782. PubMed ID: 27399001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice.
    Hallengärd D; Kakoulidou M; Lulla A; Kümmerer BM; Johansson DX; Mutso M; Lulla V; Fazakerley JK; Roques P; Le Grand R; Merits A; Liljeström P
    J Virol; 2014 Mar; 88(5):2858-66. PubMed ID: 24371047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice.
    Weber C; Büchner SM; Schnierle BS
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003684. PubMed ID: 25905779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An mRNA vaccine encoding Chikungunya virus E2-E1 protein elicits robust neutralizing antibody responses and CTL immune responses.
    Ge N; Sun J; Liu Z; Shu J; Yan H; Kou Z; Wei Y; Jin X
    Virol Sin; 2022 Apr; 37(2):266-276. PubMed ID: 35527225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A classical swine fever virus E2 fusion protein produced in plants elicits a neutralizing humoral immune response in mice and pigs.
    Park Y; Lee S; Kang H; Park M; Min K; Kim NH; Gu S; Kim JK; An DJ; Choe S; Sohn EJ
    Biotechnol Lett; 2020 Jul; 42(7):1247-1261. PubMed ID: 32323080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of oligomers of subunit vaccine candidate glycoprotein D of Herpes Simplex Virus-2 expressed in fusion with IgM Fc domain(s) in
    Singh VK; Kumar S; Dhaked RK; Ansari AS; Lohiya NK; Tapryal S
    3 Biotech; 2020 Nov; 10(11):463. PubMed ID: 33047090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera.
    Chua CL; Sam IC; Merits A; Chan YF
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004960. PubMed ID: 27571254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Fc Fusion on Folding and Immunogenicity of Middle East Respiratory Syndrome Coronavirus Spike Protein.
    Chun J; Cho Y; Park KH; Choi H; Cho H; Lee HJ; Jang H; Kim KH; Oh YK; Kim YB
    J Microbiol Biotechnol; 2019 May; 29(5):813-819. PubMed ID: 30982320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
    Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
    J Virol; 2017 May; 91(10):. PubMed ID: 28250124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fc-Mediated E2-Dimer Subunit Vaccines of Atypical Porcine Pestivirus Induce Efficient Humoral and Cellular Immune Responses in Piglets.
    Ren X; Qian P; Liu S; Chen H; Li X
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus.
    Tang J; Zhang N; Tao X; Zhao G; Guo Y; Tseng CT; Jiang S; Du L; Zhou Y
    Hum Vaccin Immunother; 2015; 11(5):1244-50. PubMed ID: 25874632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.
    Brandler S; Ruffié C; Combredet C; Brault JB; Najburg V; Prevost MC; Habel A; Tauber E; Desprès P; Tangy F
    Vaccine; 2013 Aug; 31(36):3718-25. PubMed ID: 23742993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live-attenuated CHIKV vaccine with rearranged genome replicates in vitro and induces immune response in mice.
    Tretyakova I; Joh J; Gearon M; Kraenzle J; Goedeker S; Pignataro A; Alejandro B; Lukashevich IS; Chung D; Pushko P
    PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012120. PubMed ID: 38648230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.